Efficacy and safety of the switch of Triumeq ® to generic (abacavir + lamivudine) + Tivicay®: data at 24 weeks.

CONCLUSIONS: The change from a regimen of abacavir + lamivudine + dolutegravir seems to be safe and effective at 24 weeks. PMID: 30305176 [PubMed - in process]
Source: BMC Pharmacology and Toxicology - Category: Drugs & Pharmacology Tags: BMC Pharmacol Toxicol Source Type: research